Studies have shown aberrant activation of mTOR in several rodent models of polycystic kidney disease [22], [32], [33] and treatment with rapamycin has been shown to alleviate cyst enlargement in murine models [34], [35], [36]. This evidence concerns the gene MTOR and polycystic kidney disease.